Blue stock alert: what to know as the fda lifts hold on bluebird bio treatment

Sometimes, the financial markets can be highly unpredictable. Reportedly, the U.S. Food and Drug Administration (FDA) lifted its partial clinical hold...

December 19, 2022, 11:50 am

Pfizer gains rights to experimental rsv treatment in china, hong kong, macau and singapore

Pfizer Inc. PFE, -4.12% said Monday that it will help develop and commercialize sisunatovir, LianBio's LIAN, +7.14% experimental respiratory syncytial...

December 19, 2022, 8:30 am

Madrigal's stock rallies about 200% after sharing positive data about its nash treatment candidate

Shares of Madrigal Pharmaceuticals Inc. MDGL, +1.43% soared 209.6% in premarket trading on Monday after the company shared positive data from a pivota...

December 19, 2022, 8:07 am

Dbv technologies: downgrade and tax loss selling create a buying opportunity

DBVT was recently downgraded by Goldman Sachs. It is trading lower on any timeframe you consider and hence makes a good tax loss buy ...

December 19, 2022, 7:22 am

Time to buy eli lilly (lly) and abbvie (abbv) stock for 2023?

AbbVie's valuation, in particular, makes it a potentially strong candidate for 2023, while Eli Lilly's ...

December 16, 2022, 9:49 pm

Biocryst to discontinue development of drug

Shares of BioCryst Pharmaceuticals Inc. were down about 5% in premarket trading on Thursday after the company said it halted development of BCX9930, w...

December 15, 2022, 8:52 am

Is moderna a good stock to buy right now?

Recent results suggest the company's cancer vaccine candidate can succeed where others have failed....

December 15, 2022, 5:19 am

Microsoft: get your dry powder ready for 2023

I consider Microsoft Corporation one of the most stable in its niche, but at the same time still quite expensive to buy now, even after a 23% YTD draw...

December 14, 2022, 5:49 pm

Moderna (mrna) up 20% on upbeat data from cancer jab study

Data from a mid-stage study showed that Moderna's (MRNA) personalized cancer vaccine candidate combined...

December 14, 2022, 12:47 pm

Meta tests 'candid' feature on instagram in direct challenge to bereal

Yahoo Finance Live anchors Brian Sozzi, Brad Smith and Julie Hyman report that Instagram has launched candid...

December 14, 2022, 12:28 pm

Aravive: down but not out with pivotal ovarian data due in 2023

Aravive shareholders have been heavily diluted and suffered substantial losses in 2022. The company has struggled for cash, but now says it has funds ...

December 14, 2022, 8:45 am

Ngm bio gives presentation featuring preclinical characterization of ngm936 at 2022 ash annual meeting

–NGM936, a ILT3 x CD3 bispecific T cell engager product candidate, potently induced T cell dependent ...

December 13, 2022, 12:00 am

Metafora partner wugen to present data supporting clinical development of wu-nk-101 for relapsed / refractory aml at the american society of hematology's (ash) 64th annual meeting

PARIS, France & NEW ORLEANS, La.--( BUSINESS WIRE )--METAFORA biosystems announces that its partner Wugen presented data supporting clinical developme...

December 12, 2022, 3:23 pm

Us officials met with china's vice foreign minister. talks were candid and substantial.

In geopolitical news, a senior administration official is common that:

• US officials met with China Vice Foreign Minister in China on Sun...

  December 12, 2022, 2:38 pm

Clovis enters bankruptcy with deal to sell cancer-drug candidate to novartis

Clovis Oncology, maker of ovarian cancer drug Rubraca, has filed for chapter 11 and proposed selling a separate therapy to a Novartis affiliate....

December 12, 2022, 2:05 pm

Clovis (clvs) files for bankruptcy amid lack of financial aid

Recent regulatory developments force Clovis (CLVS) to file for bankruptcy. The company inks a stalking horse agreement with Novartis for one of its pi...

December 12, 2022, 12:02 pm

Cardiol therapeutics kicks off a multi-center phase ii pilot study of cardiolrx for the treatment of recurrent pericarditis

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc revealed that it had initiated a Phase II open-label pilot study to investigate the safety and effect...

December 12, 2022, 11:59 am

Spyd: fulfill your 4% rule with this high yield etf

SPYD is a worthy candidate for income investors, with its mix of high yield combined with broad diversi...

December 12, 2022, 10:11 am

Adicet bio shares fall as it shares clinical data about its car-t treatment candidate

Adicet Bio's Inc. ACET, -13.13% stock tumbled about 38% in premarket trading on Monday after the company shared data from a Phase 1 clinical trial eva...

December 12, 2022, 8:47 am

Senti bio highlights preclinical data from logic-gated gene circuit car-nk cell therapy senti-202 at ash annual meeting and investor event

– ASH poster presentation summarizes preclinical data from SENTI-202, an off-the-shelf CAR-NK cell therapy c...

December 11, 2022, 2:00 pm